Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer

Overview of attention for article published in Breast Cancer Research, June 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 11,008 followers.

We performed in vivo drug intervention studies showing that simultaneous inhibition of EZH2 and ATM significantly increased anti-tumor activity in mice bearing BRCA1-deficient mammary tumors. https://t.co/7syu8M7n52

19 Jul 2022

Reply Repost Favourite

Happy to share this paper from L.Ratz and Dr. J. Puppe and very proud that we performed the in vivo work in our Animal Lab. https://t.co/7syu8LPLGs

20 Jun 2022

Reply Repost Favourite

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer: https://t.co/oHCFLOZlHR @BCRJournal #cancerepigenetics https://t.co/egbhzuq0UG

20 Jun 2022

Reply Repost Favourite

RT @cancerSL: Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer https://t.co/sQounssd7l

19 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.